1.	Stereotactic Body Radiotherapy for Prostate Cancer Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-022, NCT01352598
2.	External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: GU004-11, NCT01603420
3.	Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000526353, CALGB-90203, NCT00430183
4.	Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: GU002-10, NCT01230866
5.	Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000701128, RTOG-0924, NCT01368588
6.	A Phase III Trial of Hypofractionated External Beam Image-Guided Highly Targeted Radiotherapy: The HEIGHT Trial Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 35 to 85 Sponsor: Other Protocol IDs: EPROST-20100635, NCT01411332
7.	A Phase III Randomized Trial of MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 35 to 85 Sponsor: Other Protocol IDs: EPROST-20101056, NCT01411345
8.	Trial of Modifications to Radical Prostatectomy Phase: Phase III Type: Treatment Status: Active Age: 21 and over Sponsor: Other Protocol IDs: 11-096, NCT01407263
9.	Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000727326, RTOG-1115, NCT01546987
10.	Proton Therapy vs. IMRT for Low or Low-Intermediate Risk Prostate Cancer Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 11-497, NCT01617161
11.	Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 35 to 85 Sponsor: Other Protocol IDs: EPROST-20110491, NCT01794403
12.	Phase I/II Study of Stereotactic Body Radiotherapy in Patients With Low- or Intermediate-Risk Prostate Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: SCCC-062006-010, 062006-010, SCCC-0604122, NCT00547339, UMN-2006UC048
13.	Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 58116, NCT00831623
14.	Effects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing Prostatectomy Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Any age Sponsor: NCI, Other Protocol IDs: CDR0000642377, OSU-2007C0026, 2007C0026, NCT01009736
15.	Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: J1161, NCT01317199
16.	Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 50 to 90 Sponsor: Other Protocol IDs: 101091, NCT01540994
17.	A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 21 and over Sponsor: Other Protocol IDs: J1265, NA_00073453, NCT01696877
18.	Intermittent Hormone Therapy in Men With Localized Prostate Cancer After Radiation Therapy or Radical Prostatectomy Phase: Phase II Type: Treatment Status: Active Age: over 21 Sponsor: Other Protocol IDs: 30296-A, L-8863, 06-2040-A-02, NCT00223665
19.	Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000533887, RTOG-0526, NCT00450411
20.	Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 070107, 07-C-0107, NCI-07-C-0107, 7354, NCT00450463
21.	Brachytherapy for Prostatic Carcinoma Patients Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2006-0038, NCT00525720
22.	Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 to 85 Sponsor: NCI, Other Protocol IDs: CDR0000595004, JHOC-J07122, JHOC-NA_00010227, J07122, NCT00670046
23.	Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08-190, NCT00776594
24.	Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: J-0859, NA_00019393, NCT00809991
25.	CyberKnife Radiosurgery for Locally Recurrent Prostate CA Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CK Recurrent Prostate SD, NCT00851916